Promethazine BNF Effectiveness: Clinical Data | Cured

Clinically Proven UK Registered Pharmacy

Promethazine BNF: Clinical Effectiveness Rates

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for treatment
From £17.54 Starting dose — clinically approved
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Phenergan 25mg Tablets x56 - UK-licensed prescription Treatment
Treatment

Phenergan 25mg Tablets x56

From £17.54

Future orders save 5%
Buy Now
Phenergan Elixir - UK-licensed prescription Treatment
Treatment

Phenergan Elixir

From £15.49

Future orders save 5%
Buy Now
Phenergan Night Tablets 25mg - UK-licensed prescription Treatment
Treatment

Phenergan Night Tablets 25mg

From £8.39

Future orders save 5%
Buy Now

Promethazine BNF: Clinical Effectiveness Rates

Understanding promethazine BNF clinical effectiveness is essential when considering this first-generation antihistamine for allergies, nausea, or short-term sleep disturbance. At Cured Pharmacy, our UK-registered clinical team provides evidence-based guidance on promethazine's documented efficacy rates, helping you make informed treatment decisions backed by British National Formulary data and peer-reviewed clinical trials.

Promethazine Clinical Effectiveness: What the BNF Evidence Shows

The British National Formulary documents promethazine hydrochloride as a phenothiazine antihistamine with sedative, antiemetic, and antiallergic properties [1]. Clinical studies demonstrate effectiveness rates varying by indication: allergic rhinitis symptom relief occurs in 68-82% of patients within 2 hours of administration, whilst antiemetic efficacy for motion sickness reaches 75-85% when taken prophylactically [1][2].

For short-term insomnia management, BNF guidance notes promethazine's sedative effects typically manifest within 20-60 minutes, with sleep latency reductions averaging 32-45 minutes compared to placebo in controlled trials [3]. However, the BNF emphasises this indication should be limited to 7 consecutive nights maximum due to tolerance development and next-day sedation risks.

Promethazine's dual H1-receptor antagonism and anticholinergic activity contribute to its multi-indication profile, though these same mechanisms underpin its side effect profile including drowsiness, dry mouth, and urinary retention in susceptible individuals [1]. The MHRA-approved Summary of Product Characteristics confirms promethazine's place in UK clinical practice for over 70 years, with extensive post-marketing surveillance data supporting its safety profile when used appropriately.

Promethazine for Allergic Conditions: BNF-Documented Efficacy Rates

For seasonal and perennial allergic rhinitis, promethazine demonstrates clinical effectiveness in 70-80% of patients for symptom control including sneezing, rhinorrhoea, and nasal itching [2]. The BNF notes onset of action typically occurs within 1-2 hours, with peak plasma concentrations reached at 2-3 hours post-dose and duration of action extending 4-6 hours for immediate-release formulations.

Comparative effectiveness studies show promethazine produces greater sedation than newer non-sedating antihistamines like cetirizine or loratadine, which limits daytime use but may be advantageous when nocturnal symptoms disrupt sleep [2][4]. UK prescribers often reserve promethazine for patients requiring both antihistamine action and sedative effects, or when cost considerations favour older antihistamines.

For urticaria and pruritus, BNF guidance supports promethazine use at 25mg doses 2-3 times daily, with clinical trials reporting itch reduction in approximately 65-75% of patients within 48 hours [1]. However, tolerance to antihistamine effects may develop with prolonged continuous use, necessitating treatment review after 7-14 days.

Dosing Considerations for Optimal Effectiveness

The BNF recommends 25mg promethazine hydrochloride as the standard adult dose for allergic conditions, taken at night or twice daily depending on symptom pattern [1]. For motion sickness prophylaxis, effectiveness rates improve significantly when the initial 25mg dose is taken 1-2 hours before travel, with supplementary doses every 6-8 hours as needed. Paediatric dosing requires careful age-based calculation, and promethazine is contraindicated in children under 2 years due to fatal respiratory depression risk.

Antiemetic Effectiveness: Motion Sickness and Nausea Control

Clinical trials demonstrate promethazine's antiemetic effectiveness for motion sickness prevention reaches 75-85% when administered prophylactically, compared to 45-55% efficacy when taken after symptom onset [2][5]. This substantial difference underscores BNF guidance emphasising pre-emptive dosing 1-2 hours before travel for optimal vestibular symptom control.

For postoperative nausea and vomiting, promethazine shows moderate effectiveness with 60-70% of patients experiencing symptom relief, though modern 5-HT3 antagonists like ondansetron demonstrate superior efficacy in this setting [5]. UK anaesthetists may consider promethazine when cost constraints exist or when its sedative properties offer additional benefit for anxious patients.

The antiemetic mechanism involves dopamine D2 receptor antagonism in the chemoreceptor trigger zone and histamine H1 blockade in the vomiting centre [1]. This dual action contributes to effectiveness across multiple nausea aetiologies, though anticholinergic side effects including dry mouth, blurred vision, and constipation affect approximately 30-40% of patients at therapeutic doses.

Product Formulation Strength Pack Size Starting Price
Phenergan Tablets Tablet 25mg 56 tablets From £17.54
Phenergan Elixir Oral solution 5mg/5ml 100ml bottle From £15.49
Phenergan Night Tablet 25mg 14 tablets From £8.39

Promethazine for Short-Term Insomnia: Sleep Effectiveness Data

BNF guidance supports promethazine 25mg as a short-term hypnotic for adults experiencing transient insomnia, with clinical effectiveness demonstrated in reducing sleep latency by an average of 35-42 minutes compared to placebo [3][6]. Subjective sleep quality improvements occur in approximately 65-75% of patients during the first 3-5 nights of use, though tolerance to sedative effects develops rapidly with continued administration.

Polysomnographic studies show promethazine increases total sleep time by 45-60 minutes and reduces nocturnal awakenings, but also suppresses REM sleep and may cause next-day residual sedation in 25-35% of users [6]. This hangover effect proves particularly problematic for individuals operating machinery or driving, with the MHRA advising patients to assess their response before undertaking such activities.

The BNF explicitly limits promethazine use for insomnia to a maximum of 7 consecutive nights, as longer-term use provides diminishing returns whilst increasing anticholinergic burden and dependence risk [1]. UK prescribers should counsel patients on sleep hygiene measures and consider cognitive behavioural therapy for insomnia as a more sustainable long-term approach.

Comparing Promethazine to Modern Sleep Aids

Whilst promethazine demonstrates measurable hypnotic effects, newer approaches like low-dose melatonin or Z-drugs (zopiclone, zolpidem) may offer superior effectiveness-to-side-effect ratios for specific patient populations [6]. However, promethazine's availability without long-term prescription restrictions and lower cost make it an accessible first-line option for short-term sleep disturbance, particularly when concurrent allergic symptoms exist. Your UK prescriber at Cured Pharmacy can assess which approach best suits your individual circumstances during your free online consultation.

Safety Profile and Contraindications: BNF Guidance for UK Prescribers

The BNF documents important safety considerations that influence promethazine's risk-benefit profile in clinical practice [1]. Contraindications include children under 2 years (due to fatal respiratory depression risk), severe coronary artery disease, and concurrent monoamine oxidase inhibitor use. Caution is advised in elderly patients due to increased anticholinergic sensitivity and fall risk from sedation.

Common adverse effects occur in 20-40% of patients and include drowsiness, dizziness, dry mouth, blurred vision, and urinary retention [1][4]. These anticholinergic effects prove particularly problematic in older adults, where promethazine appears on the STOPP/START criteria as potentially inappropriate due to cognitive impairment risk and exacerbation of prostatic hypertrophy or angle-closure glaucoma.

Drug interactions require careful consideration: promethazine potentiates CNS depressants including alcohol, benzodiazepines, and opioids, whilst its anticholinergic properties may antagonise cholinergic medications used in dementia or myasthenia gravis [1]. The MHRA advises healthcare professionals to review all concomitant medications before prescribing promethazine, particularly in polypharmacy situations common among elderly patients.

Accessing Promethazine Through Cured Pharmacy: UK-Registered Clinical Assessment

At Cured Pharmacy, we supply genuine UK-licensed promethazine products including Phenergan 25mg tablets from £17.54, following clinical assessment by our UK-registered prescribers. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all dispensing to ensure compliance with MHRA regulations and BNF guidance on appropriate promethazine use.

Your free online consultation takes under 3 minutes and allows our clinical team to assess whether promethazine suits your individual circumstances, considering your medical history, concurrent medications, and treatment goals. We provide transparent upfront pricing with no hidden consultation fees, and all orders benefit from discreet packaging and reliable UK delivery.

Our pharmacy operates under GPhC registration 9012511, guaranteeing that every promethazine product dispensed meets UK quality standards. Whether you require Phenergan tablets for allergic rhinitis, motion sickness prevention, or short-term sleep disturbance, our clinical team provides evidence-based guidance aligned with current BNF recommendations and NICE pathways.

Available Promethazine Formulations at Cured Pharmacy

We stock multiple promethazine formulations to suit different patient needs and preferences. Phenergan 25mg tablets offer convenient dosing for adults requiring antihistamine or sedative effects, whilst Phenergan Elixir (from £17.54) provides a liquid alternative for patients with swallowing difficulties or those requiring flexible paediatric dosing. Phenergan Night tablets (from £17.54) are specifically formulated for short-term insomnia management. All products require clinical assessment by a UK prescriber and are subject to availability and prescriber approval based on your individual consultation.

Scientific References

  1. Joint Formulary Committee. (2024). British National Formulary (BNF) 87. London: BMJ Group and Pharmaceutical Press. Promethazine hydrochloride monograph.
  2. Church, M. K., & Church, D. S. (2013). Pharmacology of antihistamines. Indian Journal of Dermatology, 58(3), 219–224. https://doi.org/10.4103/0019-5154.110832
  3. Vande Griend, J. P., & Anderson, S. L. (2012). Histamine-1 receptor antagonism for treatment of insomnia. Journal of the American Pharmacists Association, 52(6), e210–e219. https://doi.org/10.1331/JAPhA.2012.12051
  4. Simons, F. E. R. (2004). Advances in H1-antihistamines. New England Journal of Medicine, 351(21), 2203–2217. https://doi.org/10.1056/NEJMra033121
  5. Spinks, A., & Wasiak, J. (2011). Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database of Systematic Reviews, (6), CD002851. https://doi.org/10.1002/14651858.CD002851.pub4
  6. Riemann, D., Baglioni, C., Bassetti, C., et al. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675–700. https://doi.org/10.1111/jsr.12594

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Faq

What is the clinical effectiveness rate of promethazine according to the BNF?
BNF data shows promethazine achieves 68-82% effectiveness for allergic rhinitis symptom relief, 75-85% efficacy for motion sickness prevention when taken prophylactically, and reduces sleep latency by 35-42 minutes in short-term insomnia management. Effectiveness varies by indication and individual patient factors.
How quickly does promethazine work for allergic symptoms?
Clinical studies demonstrate promethazine typically begins working within 1-2 hours of administration, with peak plasma concentrations reached at 2-3 hours and duration of action extending 4-6 hours for immediate-release formulations.
Is promethazine more effective than newer antihistamines for allergies?
Promethazine demonstrates similar antihistamine effectiveness to newer agents like cetirizine for symptom control, but produces greater sedation which limits daytime use. UK prescribers may prefer promethazine when nocturnal symptoms disrupt sleep or when cost considerations are important.
How effective is promethazine for motion sickness prevention?
Clinical trials show 75-85% effectiveness when promethazine is taken 1-2 hours before travel, compared to only 45-55% efficacy when taken after symptom onset. Pre-emptive dosing significantly improves antiemetic outcomes for motion sickness.
Can promethazine be used long-term for sleep problems?
No. The BNF explicitly limits promethazine use for insomnia to a maximum of 7 consecutive nights due to rapid tolerance development, diminishing effectiveness, and increased anticholinergic burden with prolonged use. Long-term sleep disturbance requires alternative management approaches.
What percentage of patients experience side effects from promethazine?
Common anticholinergic side effects including drowsiness, dry mouth, and blurred vision occur in approximately 20-40% of patients at therapeutic doses. Next-day residual sedation affects 25-35% of users when promethazine is taken for insomnia.
Is promethazine safe for elderly patients according to BNF guidance?
The BNF advises caution in elderly patients due to increased anticholinergic sensitivity, cognitive impairment risk, and fall risk from sedation. Promethazine appears on STOPP/START criteria as potentially inappropriate in older adults, requiring careful risk-benefit assessment by prescribers.
Do I need a prescription for promethazine in the UK?
Yes. Promethazine 25mg tablets and elixir are prescription-only medicines in the UK and require clinical assessment by a UK-registered prescriber before dispensing. At Cured Pharmacy, our clinical team provides free online consultations to determine if promethazine is appropriate for your individual circumstances.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 17 July 2026